Wayne Drevets - Publications

Affiliations: 
Department of Psychiatry University of Oklahoma, Norman, OK, United States 

228 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Vairavan S, Rashidisabet H, Li QS, Ness S, Morrison RL, Soares CN, Uher R, Frey BN, Lam RW, Kennedy SH, Trivedi M, Drevets WC, Narayan VA. Personalized relapse prediction in patients with major depressive disorder using digital biomarkers. Scientific Reports. 13: 18596. PMID 37903878 DOI: 10.1038/s41598-023-44592-8  0.31
2023 Recourt K, de Boer P, van der Ark P, Benes H, van Gerven JMA, Ceusters M, van Nueten L, Drevets WC, Bhatacharya A, Browning M, Jacobs GE. Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder. Translational Psychiatry. 13: 266. PMID 37482560 DOI: 10.1038/s41398-023-02557-5  0.368
2022 Floden L, Hudgens S, Jamieson C, Popova V, Drevets WC, Cooper K, Singh J. Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant. Cns Drugs. PMID 35441931 DOI: 10.1007/s40263-022-00916-2  0.321
2022 Drevets WC, Wittenberg GM, Bullmore ET, Manji HK. Immune targets for therapeutic development in depression: towards precision medicine. Nature Reviews. Drug Discovery. PMID 35039676 DOI: 10.1038/s41573-021-00368-1  0.334
2022 Chen G, Chen L, Zhang Y, Li X, Lane R, Lim P, Daly EJ, Furey ML, Fedgchin M, Popova V, Singh JB, Drevets WC. The relationship between dissociation and antidepressant effects of esketamine nasal spray in patients with treatment-resistant depression. The International Journal of Neuropsychopharmacology. PMID 35022754 DOI: 10.1093/ijnp/pyab084  0.323
2021 Savitz A, Wajs E, Zhang Y, Xu H, Etropolski M, Thase ME, Drevets W. Efficacy and safety of seltorexant as adjunctive therapy in major depressive disorder: A phase 2b, randomized, placebo-controlled, adaptive dose-finding study. The International Journal of Neuropsychopharmacology. PMID 34324636 DOI: 10.1093/ijnp/pyab050  0.392
2021 Cole JJ, McColl A, Shaw R, Lynall ME, Cowen PJ, de Boer P, Drevets WC, Harrison N, Pariante C, Pointon L, Goodyear C, Bullmore E, Cavanagh J. No evidence for differential gene expression in major depressive disorder PBMCs, but robust evidence of elevated biological ageing. Translational Psychiatry. 11: 404. PMID 34294682 DOI: 10.1038/s41398-021-01506-4  0.338
2021 Bogert J, Rofael H, Mosca K, Ross RO, Callaerts G, Wang D, Jaeger J, Narayan VA, Drevets WC, Morrison RL. A randomized, multicenter, crossover psychometric evaluation study of an iPad-administered cognitive test battery in participants with major depressive disorder who responded to treatment with oral antidepressants. Journal of Affective Disorders. 292: 261-269. PMID 34134024 DOI: 10.1016/j.jad.2021.05.046  0.354
2021 Teneralli RE, Kern DM, Cepeda MS, Gilbert JP, Drevets WC. Exploring real-world evidence to uncover unknown drug benefits and support the discovery of new treatment targets for depressive and bipolar disorders. Journal of Affective Disorders. 290: 324-333. PMID 34020207 DOI: 10.1016/j.jad.2021.04.096  0.37
2020 Hudgens S, Floden L, Blackowicz M, Jamieson C, Popova V, Fedgchin M, Drevets WC, Cooper K, Lane R, Singh J. Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant. Journal of Affective Disorders. PMID 33261932 DOI: 10.1016/j.jad.2020.11.066  0.397
2020 Perez-Ruixo C, Rossenu S, Zannikos P, Nandy P, Singh J, Drevets WC, Perez-Ruixo JJ. Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression. Clinical Pharmacokinetics. PMID 33128208 DOI: 10.1007/s40262-020-00953-4  0.321
2020 Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, Hough D, Drevets WC, Manji H, Canuso CM. Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients with Major Depressive Disorder Who Have Active Suicide Ideation with Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II). The International Journal of Neuropsychopharmacology. PMID 32861217 DOI: 10.1093/ijnp/pyaa068  0.417
2020 Le TT, Savitz J, Suzuki H, Misaki M, Teague TK, White BC, Marino JH, Wiley G, Gaffney PM, Drevets WC, McKinney BA, Bodurka J. Correction: Identification and replication of RNA-Seq gene network modules associated with depression severity. Translational Psychiatry. 10: 282. PMID 32788574 DOI: 10.1038/S41398-020-00968-2  0.563
2020 Wittenberg GM, Greene J, Vértes PE, Drevets WC, Bullmore ET. Major Depressive Disorder Is Associated With Differential Expression of Innate Immune and Neutrophil-Related Gene Networks in Peripheral Blood: A Quantitative Review of Whole-Genome Transcriptional Data From Case-Control Studies. Biological Psychiatry. PMID 32653108 DOI: 10.1016/j.biopsych.2020.05.006  0.329
2020 Singh JB, Fedgchin M, Daly EJ, Drevets WC. Relapse prevention in treatment-resistant major depressive disorder with rapid-acting antidepressants. Advances in Pharmacology (San Diego, Calif.). 89: 237-259. PMID 32616208 DOI: 10.1016/bs.apha.2020.05.002  0.375
2020 Fu DJ, Ionescu DF, Li X, Lane R, Lim P, Sanacora G, Hough D, Manji H, Drevets WC, Canuso CM. Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I). The Journal of Clinical Psychiatry. 81. PMID 32412700 DOI: 10.4088/JCP.19m13191  0.373
2020 Hudgens S, Floden L, Blacowicz M, Jamieson C, Popova V, Fedgchin M, Drevets W, Cooper K, Lane R, Singh J. 175 Determining Meaningful Change in Depression Symptoms Assessed with PHQ-9 and SDS in Treatment-resistant Depression Trials of Esketamine Nasal Spray. Cns Spectrums. 25: 311-312. PMID 32331058 DOI: 10.1017/S1092852920000917  0.491
2020 Jamieson C, Popova V, Daly E, Cooper K, Trivedi MH, Drevets W, Singh J. 119 Assessment of Health-Related Quality of Life and Health Status in Patients with Treatment-resistant Depression. Cns Spectrums. 25: 277-278. PMID 32331036 DOI: 10.1017/S1092852920000371  0.387
2020 Aluisio L, Yieh L, Wajs E, DiBernardo A, Krystal A, Drevets W, Wu Y, Gogate J, Daly E, Zannikos P, Curran V, Chen G, Singh J. 142 Withdrawal Symptom Assessment in an Esketamine Safety Study in Patients with Treatment-resistant Depression. Cns Spectrums. 25: 290. PMID 32331032 DOI: 10.1017/S1092852920000589  0.373
2020 Floden L, Hudgens S, Jamieson C, Popova V, Drevets W, Cooper K, Singh J. 149 Evaluation of Individual Items on the PHQ-9 and SDS in Patients with Treatment-Resistant Depression Treated with Esketamine Nasal Spray. Cns Spectrums. 25: 295. PMID 32331005 DOI: 10.1017/S1092852920000656  0.454
2020 Singh JB, Daly EJ, Mathews M, Fedgchin M, Popova V, Hough D, Drevets WC. Approval of esketamine for treatment-resistant depression. The Lancet. Psychiatry. 7: 232-235. PMID 32087801 DOI: 10.1016/S2215-0366(19)30533-4  0.311
2020 Sun Y, Drevets W, Turecki G, Li QS. The Relationship between Plasma Serotonin and Kynurenine Pathway Metabolite Levels and the Treatment Response to Escitalopram and Desvenlafaxine. Brain, Behavior, and Immunity. PMID 31978524 DOI: 10.1016/J.Bbi.2020.01.011  0.43
2020 Drevets W, Wittenberg G, Salvadore G, Chen G, Bullmore E. Discovering Antidepressant Signals in Trials Using Anti-Inflammatory Treatments in Autoimmune Disorders Biological Psychiatry. 87: S79. DOI: 10.1016/J.Biopsych.2020.02.224  0.308
2019 Lynall ME, Turner L, Bhatti J, Cavanagh J, de Boer P, Mondelli V, Jones D, Drevets WC, Cowen P, Harrison NA, Pariante CM, Pointon L, Clatworthy MR, Bullmore E. Peripheral Blood Cell-Stratified Subgroups of Inflamed Depression. Biological Psychiatry. PMID 32000983 DOI: 10.1016/J.Biopsych.2019.11.017  0.331
2019 Ochs-Ross R, Daly EJ, Zhang Y, Lane R, Lim P, Morrison RL, Hough D, Manji H, Drevets WC, Sanacora G, Steffens DC, Adler C, McShane R, Gaillard R, Wilkinson ST, et al. Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 31734084 DOI: 10.1016/j.jagp.2019.10.008  0.31
2019 Cosgrove KT, Burrows K, Avery JA, Kerr KL, DeVille DC, Aupperle RL, Teague TK, Drevets WC, Simmons WK. Appetite change profiles in depression exhibit differential relationships between systemic inflammation and activity in reward and interoceptive neurocircuitry. Brain, Behavior, and Immunity. PMID 31604141 DOI: 10.1016/J.Bbi.2019.10.006  0.347
2019 Recourt K, de Boer P, Zuiker R, Luthringer R, Kent J, van der Ark P, Van Hove I, van Gerven J, Jacobs G, van Nueten L, Drevets W. Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Translational Psychiatry. 9: 240. PMID 31578318 DOI: 10.1038/s41398-019-0585-4  0.303
2019 Recourt K, de Boer P, Zuiker R, Luthringer R, Kent J, van der Ark P, Van Hove I, van Gerven J, Jacobs G, van Nueten L, Drevets W. The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Translational Psychiatry. 9: 216. PMID 31481683 DOI: 10.1038/S41398-019-0553-Z  0.457
2019 Wittenberg GM, Stylianou A, Zhang Y, Sun Y, Gupta A, Jagannatha PS, Wang D, Hsu B, Curran ME, Khan S, Chen G, Bullmore ET, Drevets WC. Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders. Molecular Psychiatry. PMID 31427751 DOI: 10.1038/s41380-019-0471-8  0.368
2019 Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele HVD, Preskorn S, Manji H, ... ... Drevets WC, et al. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1). The International Journal of Neuropsychopharmacology. PMID 31290965 DOI: 10.1093/Ijnp/Pyz039  0.344
2019 Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase ME, Shelton RC, Molero P, Vieta E, Bajbouj M, Manji H, Drevets WC, et al. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. The American Journal of Psychiatry. appiajp201919020172. PMID 31109201 DOI: 10.1176/Appi.Ajp.2019.19020172  0.327
2019 Brooks S, Jacobs GE, de Boer P, Kent JM, Van Nueten L, van Amerongen G, Zuiker R, Kezic I, Luthringer R, van der Ark P, van Gerven JM, Drevets W. The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia. Journal of Psychopharmacology (Oxford, England). 269881118822258. PMID 30644312 DOI: 10.1177/0269881118822258  0.502
2019 Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele Hvd, Manjii H, Hough D, ... Drevets WC, et al. Randomized, Double-Blind Study of Fixed-Dose Intranasal Esketamine Plus Oral Antidepressant vs. Active Control in Treatment-Resistant Depression Journal of Affective Disorders. 254: 131-132. DOI: 10.1016/J.Jad.2018.10.289  0.302
2019 Ionescu D, Canuso C, Fu D, Qiu X, Lane R, Lim P, Hough D, Drevets W, Manji H. P.607 Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients at imminent risk for suicide: ASPIRE-2 study European Neuropsychopharmacology. 29: S414-S415. DOI: 10.1016/j.euroneuro.2019.09.591  0.345
2019 Fu D, Canuso C, Ionescu D, Li X, Lane R, Lim P, Hough D, Drevets W, Manji H. P.323 Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients at imminent risk for suicide: aspire-1 study European Neuropsychopharmacology. 29: S231-S232. DOI: 10.1016/j.euroneuro.2019.09.343  0.345
2019 Daly EJ, Trivedi M, Janik A, Li H, Zhang Y, Li X, Lane R, Duca AR, Hough D, Thase ME, Zajecka J, Winokur A, Divacka I, Fagiolini A, Cubala WJ, ... ... Drevets WC, et al. Esketamine nasal spray combined with an oral antidepressant for relapse prevention in treatment-resistant depression: results of a double-blind, randomized withdrawal, multicenter study (sustain-1) European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.1076  0.301
2019 Wajs E, Leah A, Morrison R, Daly E, Lane R, Lim P, Holder R, Sanacora G, Young AH, Kasper S, Sulaiman AH, Li CT, Paik JW, Manji H, Hough D, ... Drevets W, et al. Long-term safety of esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: SUSTAIN-2 phase 3 study European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.1016  0.378
2019 Popova V, Daly E, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase M, Shelton R, Molero P, Vieta E, Bajbouj M, Manji H, Drevets W, et al. Randomized, double-blind study of flexibly-dosed intranasal esketamine plus oral antidepressant vs. active control in treatment-resistant depression European Neuropsychopharmacology. 29: S35-S36. DOI: 10.1016/j.euroneuro.2018.11.1005  0.304
2019 Middeldorp CM, Drevets W, Jarvelin M, Lichtenstein P, Lundström S, Munafo M, Plomin R, Tiemeier H, Berg SMvd, Fanos V, Bartels M. Capice: Childhood And Adolescence Psychopathology: Unravelling The Complex Etiology By A Large Interdisciplinary Collaboration In Europe European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.380  0.342
2018 Guo W, Machado-Vieira R, Mathew S, Murrough JW, Charney DS, Gruenbaum M, Oquendo MA, Kadriu B, Akula N, Henter I, Yuan P, Merikangas K, Drevets W, Furey M, Mann JJ, et al. Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression. Translational Psychiatry. 8: 280. PMID 30552317 DOI: 10.1038/S41398-018-0311-7  0.501
2018 Hamilton JP, Sacchet MD, Hjørnevik T, Chin FT, Shen B, Kämpe R, Park JH, Knutson BD, Williams LM, Borg N, Zaharchuk G, Camacho MC, Mackey S, Heilig M, Drevets WC, et al. Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent C-raclopride positron emission tomography and functional magnetic resonance imaging investigation. Translational Psychiatry. 8: 264. PMID 30504860 DOI: 10.1038/S41398-018-0316-2  0.357
2018 Kling LR, Bessette KL, DelDonno SR, Ryan KA, Drevets WC, McInnis MG, Phillips ML, Langenecker SA. Cluster analysis with MOODS-SR illustrates a potential bipolar disorder risk phenotype in young adults with remitted major depressive disorder. Bipolar Disorders. PMID 30294823 DOI: 10.1111/Bdi.12693  0.365
2018 Le TT, Savitz J, Suzuki H, Misaki M, Teague TK, White BC, Marino JH, Wiley G, Gaffney PM, Drevets WC, McKinney BA, Bodurka J. Identification and replication of RNA-Seq gene network modules associated with depression severity. Translational Psychiatry. 8: 180. PMID 30185774 DOI: 10.1038/S41398-018-0234-3  0.593
2018 Richards EM, Zanotti-Fregonara P, Fujita M, Newman L, Farmer C, Ballard ED, Machado-Vieira R, Yuan P, Niciu MJ, Lyoo CH, Henter ID, Salvadore G, Drevets WC, Kolb H, Innis RB, et al. PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects. Ejnmmi Research. 8: 57. PMID 29971587 DOI: 10.1186/S13550-018-0401-9  0.385
2018 Simmons WK, Burrows K, Avery JA, Kerr KL, Taylor A, Bodurka J, Potter W, Teague TK, Drevets WC. Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states. Molecular Psychiatry. PMID 29899546 DOI: 10.1038/S41380-018-0093-6  0.667
2018 Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, Bullmore ET. Treatment-resistant depression and peripheral C-reactive protein. The British Journal of Psychiatry : the Journal of Mental Science. 1-9. PMID 29764522 DOI: 10.1192/Bjp.2018.66  0.359
2018 Young KD, Zotev V, Phillips R, Misaki M, Drevets WC, Bodurka J. Amygdala Real-Time fMRI Neurofeedback for Major Depressive Disorder: A Review. Psychiatry and Clinical Neurosciences. PMID 29687527 DOI: 10.1111/Pcn.12665  0.73
2018 Walsh AEL, Browning M, Drevets WC, Furey M, Harmer CJ. Dissociable temporal effects of bupropion on behavioural measures of emotional and reward processing in depression. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 373. PMID 29352029 DOI: 10.1098/Rstb.2017.0030  0.34
2018 Young KD, Siegle GJ, Misaki M, Zotev V, Phillips R, Drevets WC, Bodurka J. Altered task-based and resting-state amygdala functional connectivity following real-time fMRI amygdala neurofeedback training in major depressive disorder. Neuroimage. Clinical. 17: 691-703. PMID 29270356 DOI: 10.1016/J.Nicl.2017.12.004  0.767
2018 Cosgrove K, Burrows K, Kerr K, Teague K, Drevets W, Bodurka J, Simmons WK. S127. Systemic Inflammation is Associated With Stronger Coupling Between Striatum Activity and Food Pleasantness Ratings in Depression With Appetite Loss Biological Psychiatry. 83: S396-S397. DOI: 10.1016/J.Biopsych.2018.02.1018  0.613
2018 Popova V, Daly E, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase M, Shelton R, Molero P, Vieta E, Bajbouj M, Manji H, Drevets W, et al. S111. Randomized, Double-Blind Study of Flexibly-Dosed Intranasal Esketamine Plus Oral Antidepressant Vs. Active Control in Treatment-Resistant Depression Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1002  0.412
2017 Chau DT, Fogelman P, Nordanskog P, Drevets WC, Hamilton JP. Distinct Neural-Functional Effects of Treatments With Selective Serotonin Reuptake Inhibitors, Electroconvulsive Therapy, and Transcranial Magnetic Stimulation and Their Relations to Regional Brain Function in Major Depression: A Meta-analysis. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 318-326. PMID 29560920 DOI: 10.1016/j.bpsc.2017.01.003  0.391
2017 Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, Thase ME, Winokur A, Van Nueten L, Manji H, Drevets WC. Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. Jama Psychiatry. PMID 29282469 DOI: 10.1001/jamapsychiatry.2017.3739  0.372
2017 Meier TB, Drevets WC, Teague TK, Wurfel BE, Mueller SC, Bodurka J, Dantzer R, Savitz J. Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression. Brain, Behavior, and Immunity. PMID 28867283 DOI: 10.1016/J.Bbi.2017.08.024  0.63
2017 Cho HJ, Savitz J, Dantzer R, Teague TK, Drevets WC, Irwin MR. Sleep disturbance and kynurenine metabolism in depression. Journal of Psychosomatic Research. 99: 1-7. PMID 28712413 DOI: 10.1016/J.Jpsychores.2017.05.016  0.342
2017 Leday GGR, Vértes PE, Richardson S, Greene JR, Regan T, Khan S, Henderson R, Freeman TC, Pariante CM, Harrison NA, Perry VH, Drevets WC, Wittenberg GM, Bullmore ET. Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder. Biological Psychiatry. PMID 28688579 DOI: 10.1016/J.Biopsych.2017.01.021  0.516
2017 Sun Y, Wang D, Salvadore G, Hsu B, Curran M, Casper C, Vermeulen J, Kent JM, Singh J, Drevets WC, Wittenberg GM, Chen G. The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's disease. Brain, Behavior, and Immunity. PMID 28676350 DOI: 10.1016/j.bbi.2017.06.014  0.351
2017 Suzuki H, Savitz J, Kent Teague T, Gandhapudi SK, Tan C, Misaki M, McKinney BA, Irwin MR, Drevets WC, Bodurka J. Altered Populations of Natural Killer Cells, Cytotoxic T Lymphocytes, and Regulatory T Cells in Major Depressive Disorder: Association with Sleep Disturbance. Brain, Behavior, and Immunity. PMID 28645775 DOI: 10.1016/J.Bbi.2017.06.011  0.539
2017 He H, Sui J, Du Y, Yu Q, Lin D, Drevets WC, Savitz JB, Yang J, Victor TA, Calhoun VD. Co-altered functional networks and brain structure in unmedicated patients with bipolar and major depressive disorders. Brain Structure & Function. PMID 28600678 DOI: 10.1007/S00429-017-1451-X  0.761
2017 Young KD, Misaki M, Harmer CJ, Victor T, Zotev V, Phillips R, Siegle GJ, Drevets WC, Bodurka J. Real-Time Functional Magnetic Resonance Imaging Amygdala Neurofeedback Changes Positive Information Processing in Major Depressive Disorder. Biological Psychiatry. PMID 28476207 DOI: 10.1016/J.Biopsych.2017.03.013  0.825
2017 Wurfel BE, Drevets WC, Bliss SA, McMillin JR, Suzuki H, Ford BN, Morris HM, Teague TK, Dantzer R, Savitz JB. Serum kynurenic acid is reduced in affective psychosis. Translational Psychiatry. 7: e1115. PMID 28463241 DOI: 10.1038/Tp.2017.88  0.308
2017 Young KD, Bodurka J, Drevets WC. Functional neuroimaging of sex differences in autobiographical memory recall in depression. Psychological Medicine. 1-13. PMID 28446254 DOI: 10.1017/S003329171700112X  0.75
2017 Young KD, Siegle GJ, Zotev V, Phillips R, Misaki M, Yuan H, Drevets WC, Bodurka J. Randomized Clinical Trial of Real-Time fMRI Amygdala Neurofeedback for Major Depressive Disorder: Effects on Symptoms and Autobiographical Memory Recall. The American Journal of Psychiatry. appiajp201716060637. PMID 28407727 DOI: 10.1176/Appi.Ajp.2017.16060637  0.768
2017 Victor TA, Drevets WC, Misaki M, Bodurka J, Savitz J. Sex differences in neural responses to subliminal sad and happy faces in healthy individuals: Implications for depression. Journal of Neuroscience Research. 95: 703-710. PMID 27870414 DOI: 10.1002/Jnr.23870  0.805
2017 Sun Y, Wittenberg G, Chen G, Drevets W, Hsu B, Curran M. 300. Improvement in Measures of Depressed Mood and Anhedonia in Two Randomized, Placebo-Controlled Phase III Studies of Sirukumab, a Human Anti-Interleukin-6 Antibody, in Patients with Rheumatoid Arthritis Biological Psychiatry. 81: S123. DOI: 10.1136/Annrheumdis-2017-Eular.3263  0.428
2017 Young K, Siegle G, Zotev V, Drevets W, Bodurka J. 937. EEG Correlates of Real-Time fMRI Neurofeedback Amygdala Training in Depression Biological Psychiatry. 81: S379. DOI: 10.1016/J.Biopsych.2017.02.663  0.736
2017 Walsh A, Browning M, Drevets W, Furey M, Harmer C. 873. Dissociable Temporal Effects of Bupropion on Behavioural Measures of Emotional and Reward Processing in Major Depressive Disorder Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.598  0.507
2017 Yu S, Liu X, Singh J, Palmer J, Salvadore G, Canuso C, Hough D, Drevets WC, Wittenberg G, Chen G. 142. Levels of Immune Factors in Depression Subtypes of Treatment Resistant Depression Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.154  0.353
2017 Hibar D, Jaffe A, Shin JH, Hyde T, Kleinman J, Weinberger D, Drevets W, Saad Z, Furey M, Kolb H. 555. Gene Expression Differences Associated with Major Psychiatric Disorders in the Human Prefrontal Cortex and Hippocampus Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.1163  0.347
2017 Canuso C, Singh J, Fedgchin M, Alphs L, Lane R, Lim P, Pinter C, Manji H, Drevets W. 74. PERSEVERE: A Study of Esketamine for the Reduction of the Symptoms of Major Depressive Disorder, including Suicidal Ideation, in Subjects Assessed to Be at Imminent Risk for Suicide Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.085  0.42
2016 Young KD, Bodurka J, Drevets WC. Differential neural correlates of autobiographical memory recall in bipolar and unipolar depression. Bipolar Disorders. PMID 27813234 DOI: 10.1111/Bdi.12441  0.788
2016 Bhattacharya A, Drevets WC. Role of Neuro-Immunological Factors in the Pathophysiology of Mood Disorders: Implications for Novel Therapeutics for Treatment Resistant Depression. Current Topics in Behavioral Neurosciences. PMID 27677784 DOI: 10.1007/7854_2016_43  0.339
2016 Rotroff DM, Corum DG, Motsinger-Reif A, Fiehn O, Bottrel N, Drevets WC, Singh J, Salvadore G, Kaddurah-Daouk R. Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants. Translational Psychiatry. 6: e894. PMID 27648916 DOI: 10.1038/Tp.2016.145  0.368
2016 Szczepanik J, Nugent AC, Drevets WC, Khanna A, Zarate CA, Furey ML. Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder. Psychiatry Research. 254: 67-73. PMID 27366831 DOI: 10.1016/J.Pscychresns.2016.06.005  0.386
2016 Young KD, Preskorn SH, Victor T, Misaki M, Bodurka J, Drevets WC. The Effect of Mineralocorticoid and Glucocorticoid Receptor Antagonism on Autobiographical Memory Recall and Amygdala Response to Implicit Emotional Stimuli. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 27207909 DOI: 10.1093/Ijnp/Pyw036  0.778
2016 Young KD, Drevets WC, Dantzer R, Kent Teague T, Bodurka J, Savitz J. Kynurenine Pathway Metabolites are Associated with Hippocampal Activity during Autobiographical Memory Recall in Patients with Depression. Brain, Behavior, and Immunity. PMID 27091600 DOI: 10.1016/J.Bbi.2016.04.007  0.751
2016 Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, Pinter C, Murrough JW, Sanacora G, Shelton RC, Kurian B, Winokur A, Fava M, Manji H, Drevets WC, et al. A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression. The American Journal of Psychiatry. appiajp201616010037. PMID 27056608 DOI: 10.1176/Appi.Ajp.2016.16010037  0.308
2016 Misaki M, Suzuki H, Savitz J, Drevets WC, Bodurka J. Individual Variations in Nucleus Accumbens Responses Associated with Major Depressive Disorder Symptoms. Scientific Reports. 6: 21227. PMID 26880358 DOI: 10.1038/Srep21227  0.626
2016 Young KD, Drevets WC, Bodurka J, Preskorn SS. Amygdala activity during autobiographical memory recall as a biomarker for residual symptoms in patients remitted from depression. Psychiatry Research. PMID 26809279 DOI: 10.1016/J.Pscychresns.2016.01.017  0.753
2016 Simmons WK, Burrows K, Avery JA, Kerr KL, Bodurka J, Savage CR, Drevets WC. Depression-Related Increases and Decreases in Appetite: Dissociable Patterns of Aberrant Activity in Reward and Interoceptive Neurocircuitry. The American Journal of Psychiatry. appiajp201515020162. PMID 26806872 DOI: 10.1176/Appi.Ajp.2015.15020162  0.667
2016 Kent JM, Daly E, Kezic I, Lane R, Lim P, De Smedt H, De Boer P, Van Nueten L, Drevets WC, Ceusters M. Efficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI/SNRI in anxious depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 67: 66-73. PMID 26804646 DOI: 10.1016/j.pnpbp.2016.01.009  0.349
2016 Bhattacharya A, Derecki NC, Lovenberg TW, Drevets WC. Role of neuro-immunological factors in the pathophysiology of mood disorders. Psychopharmacology. PMID 26803500 DOI: 10.1007/S00213-016-4214-0  0.33
2016 Singh JB, Fedgchin M, Daly E, Xi L, Melman C, De Bruecker G, Tadic A, Sienaert P, Wiegand F, Manji H, Drevets WC, Van Nueten L. Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Biological Psychiatry. 80: 424-431. PMID 26707087 DOI: 10.1016/j.biopsych.2015.10.018  0.303
2015 Jenkins LM, Kassel MT, Gabriel LB, Gowins JR, Hymen EA, Vergés A, Calamia M, Crane NA, Jacobs RH, Ajilore O, Welsh RC, Drevets WC, Phillips ML, Zubieta JK, Langenecker SA. Amygdala and dorsomedial hyperactivity to emotional faces in youth with remitted Major Depression. Social Cognitive and Affective Neuroscience. PMID 26714574 DOI: 10.1093/Scan/Nsv152  0.392
2015 He H, Yu Q, Du Y, Vergara V, Victor TA, Drevets WC, Savitz JB, Jiang T, Sui J, Calhoun VD. Resting-state functional network connectivity in prefrontal regions differs between unmedicated patients with bipolar and major depressive disorders. Journal of Affective Disorders. 190: 483-493. PMID 26551408 DOI: 10.1016/J.Jad.2015.10.042  0.758
2015 Meier TB, Drevets WC, Wurfel BE, Ford BN, Morris HM, Victor TA, Bodurka J, Kent Teague T, Dantzer R, Savitz J. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Brain, Behavior, and Immunity. PMID 26546831 DOI: 10.1016/J.Bbi.2015.11.003  0.793
2015 Young KD, Siegle GJ, Bodurka J, Drevets WC. Amygdala Activity During Autobiographical Memory Recall in Depressed and Vulnerable Individuals: Association With Symptom Severity and Autobiographical Overgenerality. The American Journal of Psychiatry. appiajp201515010119. PMID 26541813 DOI: 10.1176/Appi.Ajp.2015.15010119  0.761
2015 Frost Bellgowan J, Molfese P, Marx M, Thomason M, Glen D, Santiago J, Gotlib IH, Drevets WC, Hamilton JP. A Neural Substrate for Behavioral Inhibition in the Risk for Major Depressive Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 841-8. PMID 26407494 DOI: 10.1016/J.Jaac.2015.08.001  0.314
2015 Savitz J, Dantzer R, Meier TB, Wurfel BE, Victor TA, McIntosh SA, Ford BN, Morris HM, Bodurka J, Teague TK, Drevets WC. Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder. Psychoneuroendocrinology. 62: 54-58. PMID 26232650 DOI: 10.1016/J.Psyneuen.2015.07.609  0.799
2015 Alvarez RP, Kirlic N, Misaki M, Bodurka J, Rhudy JL, Paulus MP, Drevets WC. Increased anterior insula activity in anxious individuals is linked to diminished perceived control. Translational Psychiatry. 5: e591. PMID 26125154 DOI: 10.1038/Tp.2015.84  0.576
2015 Young KD, Bellgowan PS, Bodurka J, Drevets WC. Autobiographical deficits correlate with gray matter volume in depressed and high risk participants. Social Cognitive and Affective Neuroscience. PMID 25925269 DOI: 10.1093/Scan/Nsv047  0.722
2015 Young KD, Bellgowan PS, Bodurka J, Drevets WC. Functional neuroimaging correlates of autobiographical memory deficits in subjects at risk for depression. Brain Sciences. 5: 144-64. PMID 25919972 DOI: 10.3390/Brainsci5020144  0.784
2015 Furey ML, Drevets WC, Szczepanik J, Khanna A, Nugent A, Zarate CA. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25820840 DOI: 10.1093/Ijnp/Pyv028  0.314
2015 Homan P, Neumeister A, Nugent AC, Charney DS, Drevets WC, Hasler G. Serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression. Translational Psychiatry. 5: e532. PMID 25781231 DOI: 10.1038/Tp.2015.25  0.382
2015 Savitz J, Drevets WC, Wurfel BE, Ford BN, Bellgowan PS, Victor TA, Bodurka J, Teague TK, Dantzer R. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain, Behavior, and Immunity. 46: 55-9. PMID 25686798 DOI: 10.1016/J.Bbi.2015.02.007  0.814
2015 Savitz J, Dantzer R, Wurfel BE, Victor TA, Ford BN, Bodurka J, Bellgowan PS, Teague TK, Drevets WC. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology. 52: 200-11. PMID 25486577 DOI: 10.1016/J.Psyneuen.2014.11.015  0.796
2015 Savitz J, Drevets WC, Smith CM, Victor TA, Wurfel BE, Bellgowan PS, Bodurka J, Teague TK, Dantzer R. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 463-71. PMID 25074636 DOI: 10.1038/Npp.2014.194  0.815
2015 Hsu B, Wang D, Sun Y, Salvadore G, Singh J, Curran M, Caers I, Drevets W, Wittenberg G, Chen G. SAT0182 Improvement in Measures of Depressed Mood and Anhedonia, and Fatigue, In a Randomized, Placebo-Controlled, Phase 2 Study of Sirukumab, A Human Anti-Interleukin-6 Antibody, In Patients with Rheumatoid Arthritis Annals of the Rheumatic Diseases. 74: 720.3-721. DOI: 10.1136/Annrheumdis-2015-Eular.4081  0.434
2015 Sun Y, Wang D, Salvadore G, Singh J, Casper C, Van Rhee F, Vermeulen J, Caers I, Kent J, Drevets W, Chen G, Wittenberg G. P.2.b.033 Siltuximab improves depressive symptoms in a randomised, placebo-controlled, phase 2 study in patients with multicentric Castlemen's disease European Neuropsychopharmacology. 25: S403-S404. DOI: 10.1016/S0924-977X(15)30532-0  0.389
2015 Hasler G, Homan P, Neumeister A, Nugent A, Charney D, Drevets W. Differenital Behavioral and Neural Consequences of Serotonin and Catecholamine Deficiency in Depression: an Experimental Study European Psychiatry. 30: 1302. DOI: 10.1016/S0924-9338(15)31019-1  0.363
2014 Misaki M, Savitz J, Zotev V, Phillips R, Yuan H, Young KD, Drevets WC, Bodurka J. Contrast enhancement by combining T1- and T2-weighted structural brain MR Images. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. PMID 25533337 DOI: 10.1002/Mrm.25560  0.607
2014 Hafeman DM, Bebko G, Bertocci MA, Fournier JC, Bonar L, Perlman SB, Travis M, Gill MK, Diwadkar VA, Sunshine JL, Holland SK, Kowatch RA, Birmaher B, Axelson D, Horwitz SM, ... ... Drevets W, et al. Abnormal deactivation of the inferior frontal gyrus during implicit emotion processing in youth with bipolar disorder: attenuated by medication. Journal of Psychiatric Research. 58: 129-36. PMID 25151338 DOI: 10.1016/J.Jpsychires.2014.07.023  0.382
2014 Young KD, Bellgowan PS, Bodurka J, Drevets WC. Neurophysiological correlates of autobiographical memory deficits in currently and formerly depressed subjects. Psychological Medicine. 44: 2951-63. PMID 25065602 DOI: 10.1017/S0033291714000464  0.775
2014 Homan P, Drevets WC, Hasler G. The effects of catecholamine depletion on the neural response to fearful faces in remitted depression. The International Journal of Neuropsychopharmacology. 17: 1419-28. PMID 24725805 DOI: 10.1017/S1461145714000339  0.354
2014 Young KD, Zotev V, Phillips R, Misaki M, Yuan H, Drevets WC, Bodurka J. Real-time FMRI neurofeedback training of amygdala activity in patients with major depressive disorder. Plos One. 9: e88785. PMID 24523939 DOI: 10.1371/Journal.Pone.0088785  0.776
2014 Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R, Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini S, ... ... Drevets W, et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging and Behavior. 8: 153-82. PMID 24399358 DOI: 10.1007/S11682-013-9269-5  0.35
2014 Avery JA, Drevets WC, Moseman SE, Bodurka J, Barcalow JC, Simmons WK. Major depressive disorder is associated with abnormal interoceptive activity and functional connectivity in the insula. Biological Psychiatry. 76: 258-66. PMID 24387823 DOI: 10.1016/J.Biopsych.2013.11.027  0.678
2014 Nugent AC, Diazgranados N, Carlson PJ, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Drevets WC, Zarate CA. Neural correlates of rapid antidepressant response to ketamine in bipolar disorder Bipolar Disorders. 16: 119-128. PMID 24103187 DOI: 10.1111/Bdi.12118  0.353
2014 Homan P, Drevets WC, Hasler G. Neural correlates of free T3 alteration after catecholamine depletion in subjects with remitted major depressive disorder and in controls. Psychopharmacology. 231: 409-17. PMID 23954912 DOI: 10.1007/s00213-013-3250-2  0.338
2014 Daly E, Kent J, Drevets W, Kezic I, Lane R, Lim P, Smedt HD, Mazzucco C, Boer PD, Nueten LV, Ceusters M. P.2.f.005 Efficacy and safety of a novel mGlu2 receptor positive allosteric modulator as an adjunctive treatment in anxious depression European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70726-6  0.377
2014 Singh J, Fedgchin M, Daly E, Boer PD, Cooper K, Lim P, Pinter C, Murrough J, Sanacora G, Shelton R, Kurian B, Winokur A, Fava M, Manji H, Drevets W, et al. P.2.b.017 Onset of efficacy of ketamine in treatment-resistant depression: a double-blind, randomised, placebo-controlled, dose frequency study European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70618-2  0.378
2013 Zotev V, Phillips R, Young KD, Drevets WC, Bodurka J. Prefrontal control of the amygdala during real-time fMRI neurofeedback training of emotion regulation. Plos One. 8: e79184. PMID 24223175 DOI: 10.1371/Journal.Pone.0079184  0.679
2013 Savitz J, Nugent AC, Bellgowan PS, Wright N, Tinsley R, Zarate CA, Herscovitch P, Drevets WC. Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study. Neuroimage. Clinical. 2: 341-55. PMID 24179788 DOI: 10.1016/J.Nicl.2013.02.004  0.334
2013 Homan P, Drevets WC, Hasler G. Growth hormone response to catecholamine depletion in unmedicated, remitted subjects with major depressive disorder and healthy controls. Journal of Clinical Psychopharmacology. 33: 621-6. PMID 23963054 DOI: 10.1097/JCP.0b013e31829a8284  0.348
2013 Nugent AC, Davis RM, Zarate CA, Drevets WC. Reduced thalamic volumes in major depressive disorder. Psychiatry Research. 213: 179-85. PMID 23850106 DOI: 10.1016/J.Pscychresns.2013.05.004  0.438
2013 Victor TA, Furey ML, Fromm SJ, Öhman A, Drevets WC. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 2195-208. PMID 23809145 DOI: 10.1017/S146114571300062X  0.79
2013 Young KD, Bellgowan PS, Bodurka J, Drevets WC. Behavioral and neurophysiological correlates of autobiographical memory deficits in patients with depression and individuals at high risk for depression. Jama Psychiatry. 70: 698-708. PMID 23677007 DOI: 10.1001/Jamapsychiatry.2013.1189  0.742
2013 Carlson PJ, Diazgranados N, Nugent AC, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Manji HK, Zarate CA, Drevets WC. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: A preliminary positron emission tomography study Biological Psychiatry. 73: 1213-1221. PMID 23540908 DOI: 10.1016/J.Biopsych.2013.02.008  0.37
2013 Furey ML, Drevets WC, Hoffman EM, Frankel E, Speer AM, Zarate CA. Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder. Jama Psychiatry. 70: 280-90. PMID 23364679 DOI: 10.1001/2013.Jamapsychiatry.60  0.386
2013 Billingsley-Marshall RL, Basso MR, Lund BC, Hernandez ER, Johnson CL, Drevets WC, McKee PA, Yates WR. Executive function in eating disorders: the role of state anxiety. The International Journal of Eating Disorders. 46: 316-21. PMID 23354876 DOI: 10.1002/Eat.22086  0.303
2013 Breitberg A, Drevets WC, Wood SE, Mah L, Schulkin J, Sahakian BJ, Erickson K. Hydrocortisone infusion exerts dose- and sex-dependent effects on attention to emotional stimuli. Brain and Cognition. 81: 247-55. PMID 23262179 DOI: 10.1016/J.Bandc.2012.10.010  0.546
2013 Drevets WC, Zarate CA, Furey ML. Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: A review Biological Psychiatry. 73: 1156-1163. PMID 23200525 DOI: 10.1016/J.Biopsych.2012.09.031  0.402
2013 Savitz J, Frank MB, Victor T, Bebak M, Marino JH, Bellgowan PS, McKinney BA, Bodurka J, Kent Teague T, Drevets WC. Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities. Brain, Behavior, and Immunity. 31: 161-71. PMID 23064081 DOI: 10.1016/J.Bbi.2012.10.007  0.821
2013 Young KD, Bellgowan PS, Bodurka J, Drevets WC. Functional neuroimaging of sex differences in autobiographical memory recall. Human Brain Mapping. 34: 3320-32. PMID 22807028 DOI: 10.1002/Hbm.22144  0.694
2013 Simmons WK, Avery JA, Barcalow JC, Bodurka J, Drevets WC, Bellgowan P. Keeping the body in mind: insula functional organization and functional connectivity integrate interoceptive, exteroceptive, and emotional awareness. Human Brain Mapping. 34: 2944-58. PMID 22696421 DOI: 10.1002/Hbm.22113  0.538
2013 Nugent AC, Davis RM, Zarate CA, Drevets WC. Reduced thalamic volumes in major depressive disorder Psychiatry Research - Neuroimaging. 213: 179-185. DOI: 10.1016/j.pscychresns.2013.05.004  0.439
2012 Young KD, Erickson K, Drevets WC. Differential effects of emotionally versus neutrally cued autobiographical memories on performance of a subsequent cognitive task: effects of task difficulty. Frontiers in Psychology. 3: 299. PMID 23060823 DOI: 10.3389/Fpsyg.2012.00299  0.682
2012 Victor TA, Furey ML, Fromm SJ, Bellgowan PS, Öhman A, Drevets WC. The extended functional neuroanatomy of emotional processing biases for masked faces in major depressive disorder. Plos One. 7: e46439. PMID 23056309 DOI: 10.1371/Journal.Pone.0046439  0.805
2012 Young KD, Erickson K, Drevets WC. Match between cue and memory valence during autobiographical memory recall in depression. Psychological Reports. 111: 129-48. PMID 23045855 DOI: 10.2466/09.02.15.Pr0.111.4.129-148  0.717
2012 Kaddurah-Daouk R, Yuan P, Boyle SH, Matson W, Wang Z, Zeng ZB, Zhu H, Dougherty GG, Yao JK, Chen G, Guitart X, Carlson PJ, Neumeister A, Zarate C, Krishnan RR, ... ... Drevets W, et al. Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Scientific Reports. 2: 667. PMID 22993692 DOI: 10.1038/Srep00667  0.478
2012 Simmons WK, Drevets WC. A "taste" of what is to come: reward sensitivity as a potential endophenotype for major depressive disorder. Biological Psychiatry. 72: 526-7. PMID 22959120 DOI: 10.1016/j.biopsych.2012.07.023  0.427
2012 Turner AD, Furey ML, Drevets WC, Zarate C, Nugent AC. Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls. Neuropsychologia. 50: 2348-55. PMID 22714007 DOI: 10.1016/J.Neuropsychologia.2012.06.003  0.477
2012 Fujita M, Hines CS, Zoghbi SS, Mallinger AG, Dickstein LP, Liow JS, Zhang Y, Pike VW, Drevets WC, Innis RB, Zarate CA. Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder. Biological Psychiatry. 72: 548-54. PMID 22677471 DOI: 10.1016/J.Biopsych.2012.04.030  0.333
2012 Gold PW, Pavlatou MG, Carlson PJ, Luckenbaugh DA, Costello R, Bonne O, Csako G, Drevets WC, Remaley AT, Charney DS, Neumeister A, Kling MA. Unmedicated, remitted patients with major depression have decreased serum immunoglobulin A. Neuroscience Letters. 520: 1-5. PMID 22579817 DOI: 10.1016/J.Neulet.2012.04.072  0.319
2012 Roiser JP, Levy J, Fromm SJ, Goldman D, Hodgkinson CA, Hasler G, Sahakian BJ, Drevets WC. Serotonin transporter genotype differentially modulates neural responses to emotional words following tryptophan depletion in patients recovered from depression and healthy volunteers. Journal of Psychopharmacology (Oxford, England). 26: 1434-42. PMID 22495688 DOI: 10.1177/0269881112442789  0.374
2012 Robinson OJ, Cools R, Carlisi CO, Sahakian BJ, Drevets WC. Ventral striatum response during reward and punishment reversal learning in unmedicated major depressive disorder. The American Journal of Psychiatry. 169: 152-9. PMID 22420038 DOI: 10.1176/appi.ajp.2011.11010137  0.403
2012 Savitz J, Nugent AC, Cannon DM, Carlson PJ, Davis R, Neumeister A, Rallis-Frutos D, Fromm S, Herscovitch P, Drevets WC. Effects of arterial cannulation stress on regional cerebral blood flow in major depressive disorder. Scientific Reports. 2: 308. PMID 22403745 DOI: 10.1038/srep00308  0.328
2012 Yuan H, Zotev V, Phillips R, Drevets WC, Bodurka J. Spatiotemporal dynamics of the brain at rest--exploring EEG microstates as electrophysiological signatures of BOLD resting state networks. Neuroimage. 60: 2062-72. PMID 22381593 DOI: 10.1016/J.Neuroimage.2012.02.031  0.515
2012 Savitz J, Preskorn S, Teague TK, Drevets D, Yates W, Drevets W. Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial. Bmj Open. 2: e000643. PMID 22357572 DOI: 10.1136/Bmjopen-2011-000643  0.477
2012 Furey ML, Nugent AC, Speer AM, Luckenbaugh DA, Hoffman EM, Frankel E, Drevets WC, Zarate CA. Baseline mood-state measures as predictors of antidepressant response to scopolamine. Psychiatry Research. 196: 62-7. PMID 22349648 DOI: 10.1016/J.Psychres.2012.01.003  0.357
2012 Moses-Kolko EL, Price JC, Wisner KL, Hanusa BH, Meltzer CC, Berga SL, Grace AA, di Scalea TL, Kaye WH, Becker C, Drevets WC. Postpartum and depression status are associated with lower [[¹¹C]raclopride BP(ND) in reproductive-age women. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1422-32. PMID 22257897 DOI: 10.1038/Npp.2011.328  0.393
2012 Price JL, Drevets WC. Neural circuits underlying the pathophysiology of mood disorders. Trends in Cognitive Sciences. 16: 61-71. PMID 22197477 DOI: 10.1016/j.tics.2011.12.011  0.344
2012 Salvadore G, van der Veen JW, Zhang Y, Marenco S, Machado-Vieira R, Baumann J, Ibrahim LA, Luckenbaugh DA, Shen J, Drevets WC, Zarate CA. An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1063-72. PMID 22040773 DOI: 10.1017/S1461145711001593  0.326
2012 Drevets WC. Neuroplasticity in mood disorders. Dialogues in Clinical Neuroscience. 6: 199-216. PMID 22033747  0.451
2012 Young KD, Erickson K, Nugent AC, Fromm SJ, Mallinger AG, Furey ML, Drevets WC. Functional anatomy of autobiographical memory recall deficits in depression. Psychological Medicine. 42: 345-57. PMID 21798113 DOI: 10.1017/S0033291711001371  0.752
2012 Savitz J, Frank B, Mckinney B, Teague TK, Drevets W. 45. Increased PBMC expression of inflammation and neurological disease-associated genes correlates with anhedonia, the BOLD response to masked happy faces and subgenual anterior cingulate cortex volume in patients with primary mood disorders Brain Behavior and Immunity. 26. DOI: 10.1016/J.Bbi.2012.07.069  0.482
2011 Young K, Drevets WC, Schulkin J, Erickson K. Dose-dependent effects of hydrocortisone infusion on autobiographical memory recall. Behavioral Neuroscience. 125: 735-41. PMID 21942435 DOI: 10.1037/A0024764  0.673
2011 Zotev V, Krueger F, Phillips R, Alvarez RP, Simmons WK, Bellgowan P, Drevets WC, Bodurka J. Self-regulation of amygdala activation using real-time FMRI neurofeedback. Plos One. 6: e24522. PMID 21931738 DOI: 10.1371/Journal.Pone.0024522  0.59
2011 Murray EA, Wise SP, Drevets WC. Localization of dysfunction in major depressive disorder: prefrontal cortex and amygdala. Biological Psychiatry. 69: e43-54. PMID 21111403 DOI: 10.1016/j.biopsych.2010.09.041  0.375
2011 Savitz JB, Nugent AC, Bogers W, Roiser JP, Bain EE, Neumeister A, Zarate CA, Manji HK, Cannon DM, Marrett S, Henn F, Charney DS, Drevets WC. Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study. Biological Psychiatry. 69: 336-43. PMID 21094939 DOI: 10.1016/J.Biopsych.2010.09.027  0.447
2011 Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R, Cannon DM, Neumeister A, Zarate CA, Drevets WC. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage. 54: 2643-51. PMID 21073959 DOI: 10.1016/J.Neuroimage.2010.11.011  0.443
2011 Mah L, Zarate CA, Nugent AC, Singh JB, Manji HK, Drevets WC. Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression International Journal of Neuropsychopharmacology. 14: 545-551. PMID 21029512 DOI: 10.1017/S1461145710001203  0.398
2010 Nugent AC, Bain EE, Thayer JF, Sollers JJ, Drevets WC. Heart rate variability during motor and cognitive tasks in females with major depressive disorder. Psychiatry Research. 191: 1-8. PMID 21129936 DOI: 10.1016/j.pscychresns.2010.08.013  0.344
2010 Victor TA, Furey ML, Fromm SJ, Ohman A, Drevets WC. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Archives of General Psychiatry. 67: 1128-38. PMID 21041614 DOI: 10.1001/Archgenpsychiatry.2010.144  0.808
2010 Du J, Wei Y, Liu L, Wang Y, Khairova R, Blumenthal R, Tragon T, Hunsberger JG, Machado-Vieira R, Drevets W, Wang YT, Manji HK. A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors. Proceedings of the National Academy of Sciences of the United States of America. 107: 11573-8. PMID 20534517 DOI: 10.1073/Pnas.0913138107  0.352
2010 Salvadore G, Cornwell BR, Sambataro F, Latov D, Colon-Rosario V, Carver F, Holroyd T, DiazGranados N, Machado-Vieira R, Grillon C, Drevets WC, Zarate CA. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1415-22. PMID 20393460 DOI: 10.1038/Npp.2010.24  0.357
2010 Drevets WC, Furey ML. Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biological Psychiatry. 67: 432-8. PMID 20074703 DOI: 10.1016/j.biopsych.2009.11.021  0.413
2010 Fujita M, Mallinger AG, Zarate CA, Dickstein LP, Zoghbi SS, Pike VW, Zhang Y, Innis RB, Drevets WC. Changes of brain phosphodiesterase 4 in major depression Neuroimage. 52: S51. DOI: 10.1016/J.Neuroimage.2010.04.232  0.338
2009 Roiser JP, Levy J, Fromm SJ, Nugent AC, Talagala SL, Hasler G, Henn FA, Sahakian BJ, Drevets WC. The effects of tryptophan depletion on neural responses to emotional words in remitted depression. Biological Psychiatry. 66: 441-50. PMID 19539268 DOI: 10.1016/j.biopsych.2009.05.002  0.323
2009 Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neuroscience and Biobehavioral Reviews. 33: 699-771. PMID 19428491 DOI: 10.1016/j.neubiorev.2009.01.004  0.377
2009 Hasler G, Luckenbaugh DA, Snow J, Meyers N, Waldeck T, Geraci M, Roiser J, Knutson B, Charney DS, Drevets WC. Reward processing after catecholamine depletion in unmedicated, remitted subjects with major depressive disorder. Biological Psychiatry. 66: 201-5. PMID 19393989 DOI: 10.1016/J.Biopsych.2009.02.029  0.353
2009 Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW, Drevets WC, Manji HK. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. The Journal of Clinical Psychiatry. 70: 699-705. PMID 19389332 DOI: 10.4088/Jcp.07M03745  0.358
2009 Savitz JB, Drevets WC. Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience. 164: 300-30. PMID 19358877 DOI: 10.1016/j.neuroscience.2009.03.082  0.303
2009 Preskorn SH, Drevets WC. Neuroscience basis of clinical depression: implications for future antidepressant drug development. Journal of Psychiatric Practice. 15: 125-32. PMID 19339846 DOI: 10.1097/01.pra.0000348365.96300.07  0.337
2009 Roiser JP, Cannon DM, Gandhi SK, Taylor Tavares J, Erickson K, Wood S, Klaver JM, Clark L, Zarate CA, Sahakian BJ, Drevets WC. Hot and cold cognition in unmedicated depressed subjects with bipolar disorder. Bipolar Disorders. 11: 178-89. PMID 19267700 DOI: 10.1111/J.1399-5618.2009.00669.X  0.668
2009 Vythilingam M, Nelson EE, Scaramozza M, Waldeck T, Hazlett G, Southwick SM, Pine DS, Drevets W, Charney DS, Ernst M. Reward circuitry in resilience to severe trauma: an fMRI investigation of resilient special forces soldiers. Psychiatry Research. 172: 75-7. PMID 19243926 DOI: 10.1016/J.Pscychresns.2008.06.008  0.301
2009 Fujimura Y, Yasuno F, Farris A, Liow JS, Geraci M, Drevets W, Pine DS, Ghose S, Lerner A, Hargreaves R, Burns HD, Morse C, Pike VW, Innis RB. Decreased neurokinin-1 (substance P) receptor binding in patients with panic disorder: positron emission tomographic study with [18F]SPA-RQ. Biological Psychiatry. 66: 94-7. PMID 19200949 DOI: 10.1016/J.Biopsych.2008.12.027  0.317
2009 Cannon DM, Klaver JM, Peck SA, Rallis-Voak D, Erickson K, Drevets WC. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1277-87. PMID 18946469 DOI: 10.1038/Npp.2008.194  0.612
2009 Szczepanik J, Martin-Soelch C, Barhaghi K, Fromm S, Drevets W. Modulation of hemodynamic response to working memory task by monetary incentive in bipolar disorder Neuroimage. 47. DOI: 10.1016/S1053-8119(09)71375-8  0.388
2009 Savitz J, Drevets W, Bogers W, Wright N, Solomon G, Nugent A, Bonne O. Increased Left Subgenual Prefrontal Cortex and Right Infralimbic Cortex Volumes in Post-Traumatic Stress Disorder Neuroimage. 47. DOI: 10.1016/S1053-8119(09)70091-6  0.317
2008 Holmes MK, Erickson K, Luckenbaugh DA, Drevets WC, Bain EE, Cannon DM, Snow J, Sahakian BJ, Manji HK, Zarate CA. A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression. Bipolar Disorders. 10: 806-15. PMID 19032712 DOI: 10.1111/J.1399-5618.2008.00628.X  0.647
2008 Nugent AC, Neumeister A, Goldman D, Herscovitch P, Charney DS, Drevets WC. Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletion. Neuroimage. 43: 764-74. PMID 18718871 DOI: 10.1016/J.Neuroimage.2008.07.040  0.324
2008 Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure & Function. 213: 93-118. PMID 18704495 DOI: 10.1007/s00429-008-0189-x  0.395
2008 Drevets WC, Savitz J, Trimble M. The subgenual anterior cingulate cortex in mood disorders. Cns Spectrums. 13: 663-81. PMID 18704022 DOI: 10.1017/s1092852900013754  0.457
2008 Taylor Tavares JV, Clark L, Furey ML, Williams GB, Sahakian BJ, Drevets WC. Neural basis of abnormal response to negative feedback in unmedicated mood disorders. Neuroimage. 42: 1118-26. PMID 18586109 DOI: 10.1016/j.neuroimage.2008.05.049  0.476
2008 Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, Waldeck T, Geraci M, Roiser JP, Neumeister A, Meyers N, Charney DS, Drevets WC. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Archives of General Psychiatry. 65: 521-31. PMID 18458204 DOI: 10.1001/Archpsyc.65.5.521  0.409
2008 Czermak C, Hauger R, Drevets WC, Luckenbaugh DA, Geraci M, Charney DS, Neumeister A. Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression. Journal of Affective Disorders. 110: 277-81. PMID 18281099 DOI: 10.1016/J.Jad.2008.01.014  0.35
2008 Moses-Kolko EL, Wisner KL, Price JC, Berga SL, Drevets WC, Hanusa BH, Loucks TL, Meltzer CC. Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study Fertility and Sterility. 89: 685-692. PMID 17543959 DOI: 10.1016/j.fertnstert.2007.03.059  0.38
2008 Nugent A, Bain E, Thayer J, Sollers J, Drevets W. Alterations in neural correlates of autonomic control in females with major depressive disorder International Journal of Psychophysiology. 69: 195. DOI: 10.1016/J.IJPSYCHO.2008.05.526  0.423
2008 Nugent A, Bain E, Sollers J, Thayer J, Drevets W. Alterations in neural correlates of autonomic control in females with and without major depressive disorder International Journal of Psychophysiology. 69: 194. DOI: 10.1016/J.IJPSYCHO.2008.05.524  0.423
2007 Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review Nuclear Medicine and Biology. 34: 865-877. PMID 17921037 DOI: 10.1016/J.Nucmedbio.2007.06.008  0.472
2007 Drevets WC. Orbitofrontal cortex function and structure in depression. Annals of the New York Academy of Sciences. 1121: 499-527. PMID 17872395 DOI: 10.1196/annals.1401.029  0.477
2007 Taylor Tavares JV, Clark L, Cannon DM, Erickson K, Drevets WC, Sahakian BJ. Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biological Psychiatry. 62: 917-24. PMID 17825802 DOI: 10.1016/J.Biopsych.2007.05.034  0.685
2007 Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS, Manji HK, Drevets WC. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biological Psychiatry. 62: 870-7. PMID 17678634 DOI: 10.1016/J.Biopsych.2007.03.016  0.447
2007 Theodore WH, Hasler G, Giovacchini G, Kelley K, Reeves-Tyer P, Herscovitch P, Drevets W. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia. 48: 1526-30. PMID 17442003 DOI: 10.1111/j.1528-1167.2007.01089.x  0.365
2006 Mah L, Zarate CA, Singh J, Duan YF, Luckenbaugh DA, Manji HK, Drevets WC. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biological Psychiatry. 61: 765-75. PMID 17027930 DOI: 10.1016/J.Biopsych.2006.06.009  0.394
2006 Furey ML, Drevets WC. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Archives of General Psychiatry. 63: 1121-9. PMID 17015814 DOI: 10.1001/ARCHPSYC.63.10.1121  0.324
2006 Neumeister A, Hu XZ, Luckenbaugh DA, Schwarz M, Nugent AC, Bonne O, Herscovitch P, Goldman D, Drevets WC, Charney DS. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Archives of General Psychiatry. 63: 978-86. PMID 16953000 DOI: 10.1001/Archpsyc.63.9.978  0.381
2006 Cannon DM, Carson RE, Nugent AC, Eckelman WC, Kiesewetter DO, Williams J, Rollis D, Drevets M, Gandhi S, Solorio G, Drevets WC. Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. Archives of General Psychiatry. 63: 741-7. PMID 16818863 DOI: 10.1001/archpsyc.63.7.741  0.423
2006 Kaplan JS, Erickson K, Luckenbaugh DA, Weiland-Fiedler P, Geraci M, Sahakian BJ, Charney D, Drevets WC, Neumeister A. Differential performance on tasks of affective processing and decision-making in patients with Panic Disorder and Panic Disorder with comorbid Major Depressive Disorder. Journal of Affective Disorders. 95: 165-71. PMID 16793143 DOI: 10.1016/J.Jad.2006.04.016  0.6
2006 Carlson PJ, Singh JB, Zarate CA, Drevets WC, Manji HK. Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 22-41. PMID 16490411 DOI: 10.1016/J.Nurx.2005.12.009  0.315
2006 Neumeister A, Drevets WC, Belfer I, Luckenbaugh DA, Henry S, Bonne O, Herscovitch P, Goldman D, Charney DS. Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1750-6. PMID 16407897 DOI: 10.1038/Sj.Npp.1301010  0.33
2006 Nugent AC, Milham MP, Bain EE, Mah L, Cannon DM, Marrett S, Zarate CA, Pine DS, Price JL, Drevets WC. Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage. 30: 485-97. PMID 16256376 DOI: 10.1016/J.Neuroimage.2005.09.029  0.304
2006 Carlson P, Bain E, Tinsley R, Nugent A, Carson R, Luckenbaugh D, Alesci S, Kling M, Gold P, Drevets W. Serotonin-1A receptor binding in depression: Correlates with interleukin-6 and the hypothalamic–pituitary–adrenal axis Neuroimage. 31. DOI: 10.1016/J.Neuroimage.2006.04.156  0.396
2005 Erickson K, Drevets WC, Clark L, Cannon DM, Bain EE, Zarate CA, Charney DS, Sahakian BJ. Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder. The American Journal of Psychiatry. 162: 2171-3. PMID 16263859 DOI: 10.1176/Appi.Ajp.162.11.2171  0.681
2005 Coryell W, Nopoulos P, Drevets W, Wilson T, Andreasen NC. Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and prognostic implications. The American Journal of Psychiatry. 162: 1706-12. PMID 16135631 DOI: 10.1176/Appi.Ajp.162.9.1706  0.515
2005 Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J, Drevets WC, Charney DS. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biological Psychiatry. 58: 969-73. PMID 16043137 DOI: 10.1016/J.Biopsych.2005.05.017  0.414
2005 Neumeister A, Charney DS, Drevets WC. Hippocampus, VI. Depression and the Hippocampus. The American Journal of Psychiatry. 162: 1057. PMID 15930051 DOI: 10.1176/Appi.Ajp.162.6.1057  0.395
2005 Neumeister A, Wood S, Bonne O, Nugent AC, Luckenbaugh DA, Young T, Bain EE, Charney DS, Drevets WC. Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biological Psychiatry. 57: 935-7. PMID 15820716 DOI: 10.1016/J.Biopsych.2005.01.016  0.417
2005 Cannon DM, Nugent AC, Erickson K, Carson RE, Eckelman WC, Kiesewetter DO, Bain EE, Gandhi SK, Solorio G, Charney D, Drevets WC. Muscarinic cholinergic2 receptor binding in bipolar disorder: Relation to saliency of affective-words Journal of Cerebral Blood Flow & Metabolism. 25: S420-S420. DOI: 10.1038/Sj.Jcbfm.9591524.0420  0.543
2004 Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, Bain EE, Luckenbaugh DA, Herscovitch P, Charney DS, Drevets WC. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Archives of General Psychiatry. 61: 765-73. PMID 15289275 DOI: 10.1001/Archpsyc.61.8.765  0.41
2004 Hasler G, Drevets WC, Manji HK, Charney DS. Discovering endophenotypes for major depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1765-81. PMID 15213704 DOI: 10.1038/Sj.Npp.1300506  0.392
2003 Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biological Psychiatry. 54: 515-28. PMID 12946880 DOI: 10.1016/S0006-3223(03)00171-9  0.419
2003 Taylor Tavares JV, Drevets WC, Sahakian BJ. Cognition in mania and depression. Psychological Medicine. 33: 959-67. PMID 12946080  0.322
2003 Erickson K, Drevets W, Schulkin J. Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states. Neuroscience and Biobehavioral Reviews. 27: 233-46. PMID 12788335 DOI: 10.1016/S0149-7634(03)00033-2  0.574
2003 Drevets WC. Neuroimaging abnormalities in the amygdala in mood disorders. Annals of the New York Academy of Sciences. 985: 420-44. PMID 12724175 DOI: 10.1111/j.1749-6632.2003.tb07098.x  0.468
2002 Drevets WC, Bogers W, Raichle ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 527-44. PMID 12468016 DOI: 10.1016/S0924-977X(02)00102-5  0.321
2002 Bowley MP, Drevets WC, Ongür D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biological Psychiatry. 52: 404-12. PMID 12242056 DOI: 10.1016/S0006-3223(02)01404-X  0.404
2002 Gold PW, Drevets WC, Charney DS. New insights into the role of cortisol and the glucocorticoid receptor in severe depression Biological Psychiatry. 52: 381-385. PMID 12242053 DOI: 10.1016/S0006-3223(02)01480-4  0.342
2002 Botteron KN, Raichle ME, Drevets WC, Heath AC, Todd RD. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biological Psychiatry. 51: 342-4. PMID 11958786 DOI: 10.1016/S0006-3223(01)01280-X  0.313
2002 Drevets WC, Price JL, Bardgett ME, Reich T, Todd RD, Raichle ME. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacology, Biochemistry, and Behavior. 71: 431-47. PMID 11830178 DOI: 10.1016/S0091-3057(01)00687-6  0.375
2002 Ketter TA, Drevets WC. Neuroimaging studies of bipolar depression: functional neuropathology, treatment effects, and predictors of clinical response Clinical Neuroscience Research. 2: 182-192. DOI: 10.1016/S1566-2772(02)00043-9  0.378
2001 Thomas KM, Drevets WC, Dahl RE, Ryan ND, Birmaher B, Eccard CH, Axelson D, Whalen PJ, Casey BJ. Amygdala response to fearful faces in anxious and depressed children. Archives of General Psychiatry. 58: 1057-63. PMID 11695953 DOI: 10.1001/Archpsyc.58.11.1057  0.38
2001 Levine J, Chengappa KN, Gershon S, Drevets W. Differentiating primary pathophysiologic from secondary adaptational processes. Depression and Anxiety. 14: 105-11. PMID 11668663 DOI: 10.1002/da.1052  0.329
2001 Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression Nature Medicine. 7: 541-547. PMID 11329053 DOI: 10.1038/87865  0.391
2001 Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology. 11: 240-9. PMID 11301246 DOI: 10.1016/S0959-4388(00)00203-8  0.437
2001 Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Progress in Brain Research. 126: 413-31. PMID 11105660 DOI: 10.1016/S0079-6123(00)26027-5  0.446
2000 Drevets WC. Neuroimaging studies of mood disorders. Biological Psychiatry. 48: 813-29. PMID 11063977 DOI: 10.1016/S0006-3223(00)01020-9  0.426
2000 Casey BJ, Thomas KM, Eccard CH, Drevets WC, Dahl RE, Whalen PJ, Perrett DI, Ryan ND. Functional responsivity of the amygdala in children with disorders of anxiety and major depression Neuroimage. 11: S249. DOI: 10.1016/S1053-8119(00)91181-9  0.384
1999 Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry. 46: 1375-1387. PMID 10578452 DOI: 10.1016/S0006-3223(99)00189-4  0.411
1999 Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Annals of the New York Academy of Sciences. 877: 614-37. PMID 10415674 DOI: 10.1111/j.1749-6632.1999.tb09292.x  0.454
1998 Drevets WC, Ongür D, Price JL. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Molecular Psychiatry. 3: 220-6, 190-1. PMID 9672897 DOI: 10.1038/Sj.Mp.4000370  0.35
1998 Drevets WC, Ongür D, Price JL. Reduced glucose metabolism in the subgenual prefrontal cortex in unipolar depression. Molecular Psychiatry. 3: 190-1. PMID 9672886  0.304
1998 Drevets WC. Functional neuroimaging studies of depression: the anatomy of melancholia. Annual Review of Medicine. 49: 341-61. PMID 9509268 DOI: 10.1146/ANNUREV.MED.49.1.341  0.414
1997 Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M, Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386: 824-7. PMID 9126739 DOI: 10.1038/386824A0  0.443
1997 Drevets W, Price J. Prefrontal cortical abnormalities in neuroimaging studies of depression: Implications for studies of dopaminergic function Biological Psychiatry. 42: 269S. DOI: 10.1016/S0006-3223(97)88042-0  0.386
1997 Drevets W, Ralchle M. Functional anatomical correlates of unipolar versus bipolar depression: Potential effects of neuromorphometric differences Biological Psychiatry. 42: 217S. DOI: 10.1016/S0006-3223(97)87803-1  0.425
1992 Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME. A functional anatomical study of unipolar depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 3628-41. PMID 1527602 DOI: 10.1523/Jneurosci.12-09-03628.1992  0.464
Show low-probability matches.